Page last updated: 2024-08-17

rotenone and Familial Nonmedullary Thyroid Cancer

rotenone has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goncalves, AP; Maximo, V; Soares, P; Videira, A	1

Other Studies

1 other study(ies) available for rotenone and Familial Nonmedullary Thyroid Cancer

Article	Year
Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. Journal of biosciences, 2011, Volume: 36, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Humans; Oncogene Proteins, Fusion; Patched Receptors; Proto-Oncogene Proteins c-ret; Receptors, Cell Surface; Rotenone; Staurosporine; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms	2011

Article

Year

Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.

Journal of biosciences, 2011, Volume: 36, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Humans; Oncogene Proteins, Fusion; Patched Receptors; Proto-Oncogene Proteins c-ret; Receptors, Cell Surface; Rotenone; Staurosporine; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms

2011